References
- 1. Adlhoch C., M. Hoehne, M. Littmann, et al. Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany: 2010–2011 Pediatr Infect Dis J, 32 (2) (2013), e82–e89.10.1097/INF.0b013e3182720b7123334342
- 2. Bellido-BlascoJ.B., S. Sabater-Vidal, MdM Salvador-Ribera, et al. Rotavirus vaccination effectiveness: a case-case study in the EDICS project, Castellon (Spain) Vaccine, 30 (52) (2012), 7536–7540.10.1016/j.vaccine.2012.10.04923103196
- 3. Braeckman T, K. Van Herck, N. Meyer, et al. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study BMJ, 345 (2012), e4752.10.1136/bmj.e4752341443422875947
- 4. Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s National Childhood vaccine schedule. Pediatr Infect Dis J 2011 Jan; 30(1 Suppl): S25-9.10.1097/INF.0b013e3181fefdee21183837
- 5. Castilla J, X. Beristain, V. Martinez-Artola, et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre: Spain Vaccine, 30 (3) (2012), 539–543.10.1016/j.vaccine.2011.11.07122122860
- 6. Folorunso OS, Sebolai OM. Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines. Vaccines (Basel). 2020 Jun 27; 8(3): E341. doi: 10.3390/vaccines8030341.10.3390/vaccines8030341756591232604982
- 7. Gervasi G, Capanna A, Mita V, Zaratti L, Franco E. Nosocomial rotavirus infection: An up to date evaluation of European studies.Hum Vaccin Immunother. 2016 Sep; 12(9):2413-8. doi: 10.1080/21645515.2016.1183858. Epub 2016 May 16.
- 8. Ghazanfar H, Naseem S, Ghazanfar A, Haq S. Rotavirus vaccine--a new hope.J Pak Med Assoc. 2014 Oct; 64(10): 1211–6.
- 9. Gleizes O, Desselberger U, Tatochenko V,et al. Nosocomialrotavirus infection in European countries: a review of the epidemiology, severity, and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 2006; 25: S12–21.10.1097/01.inf.0000197563.03895.9116397425
- 10. Hemming M, Huhti L, Räsänen S, Salminen M, Vesikari T. Rotavirus antigenemia in children is associated with more severe clinical manifestations of acute gastroenteritis. Pediatr Infect Dis J. 2014 Apr; 33(4): 366–71. doi: 10.1097/INF.0000000000000118.10.1097/INF.000000000000011824136370
- 11. Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014.Vaccine. 2015 Apr 27; 33(18): 2097–107. doi: 10.1016/j.vaccine.2015.03.016. Epub 2015 Mar 18.
- 12. Muhsen K, G. Chodick, S. Goren, V. Shalev, D. Cohen The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community Vaccine, 29 (1) (2010), 91–94.10.1016/j.vaccine.2010.10.01020969927
- 13. Paulke-Korinek M, H. Kollaritsch, S.W. Aberle, et al. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austrian Vaccine, 31 (24) (2013), 2686–2691358.10.1016/j.vaccine.2013.04.00123597718
- 14. Rheingans RD, Heylen J, Giaquinto C. Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense? Pediatr Infect Dis J 2006; 25: S48–55.10.1097/01.inf.0000197566.47750.3d16397429
- 15. Rivero-Calle I, Gómez-Rial J, Martinón-Torres F. Systemic features of rotavirus infection. J Infect. 2016 Jul 5; 72 Suppl: S98-S105. doi: 10.1016/j. jinf.2016.04.029. Epub 2016 May 12.
- 16. Shaheen MNF. Rotavirus gastroenteritis among hospitalized children under 5 years of age in the Eastern Mediterranean Region: a review. East Mediterr Health J. 2019 Aug 19; 25(6): 422–430. doi: 10.26719/emhj.18.054.10.26719/emhj.18.05431469162
- 17. Stojkovska S et al .Evaluation of a rotavirus acute gastroenteritis severity score in hospitalized children over a ten year period in a clinic of infectious diseases, Skopje, R. Macedonia; contributions Sec.Med.Sci., XXXIV 2, 2013.
- 18. Vesikari T, M. Uhari, M. Renko, et al. Impact and effectiveness of RotaTeq vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland Pediatr Infect Dis J, 32 (12) (2013), 1365–1373.10.1097/INF.000000000000008624051998
- 19. Tissera MS, Cowley D, Bogdanovic-Sakran N, Hutton ML, Lyras D, Kirkwood CD, Buttery JP. Options for improving effectiveness of rotavirus vaccines in developing countries. Hum Vaccin Immunother. 2017 Apr 3; 13(4): 921–927. doi: 10.1080/21645515.2016.1252493. Epub 2016 Nov 11.
- 20. Vlasova AN, Kandasamy S, Chattha KS, Rajashekara G, Saif LJ. Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species. Vet Immunol Immunopathol. 2016 Apr; 172: 72–84. doi: 10.1016/j.vetimm.2016.01.003. Epub 2016 Jan 14.